Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Change in Inventory (2017 - 2025)

Historic Change in Inventory for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $885000.0.

  • Puma Biotechnology's Change in Inventory rose 11388.02% to $885000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 32631.4%. This contributed to the annual value of $1.6 million for FY2024, which is 3563.04% down from last year.
  • Per Puma Biotechnology's latest filing, its Change in Inventory stood at $885000.0 for Q3 2025, which was up 11388.02% from -$160000.0 recorded in Q2 2025.
  • Puma Biotechnology's 5-year Change in Inventory high stood at $6.1 million for Q4 2024, and its period low was -$6.4 million during Q3 2024.
  • In the last 5 years, Puma Biotechnology's Change in Inventory had a median value of -$97000.0 in 2021 and averaged $316947.4.
  • In the last 5 years, Puma Biotechnology's Change in Inventory soared by 327874.02% in 2021 and then crashed by 85463.92% in 2022.
  • Quarter analysis of 5 years shows Puma Biotechnology's Change in Inventory stood at -$97000.0 in 2021, then crashed by 854.64% to -$926000.0 in 2022, then surged by 251.3% to $1.4 million in 2023, then soared by 331.91% to $6.1 million in 2024, then crashed by 85.37% to $885000.0 in 2025.
  • Its Change in Inventory stands at $885000.0 for Q3 2025, versus -$160000.0 for Q2 2025 and $27000.0 for Q1 2025.